IPC organized a scientific conclave on Indian Pharmacopoeia 2026 at NIPER Hyderabad focusing on reference and impurity standards.
The event brought together regulatory, industry, and clinical experts to discuss pharmaceutical quality and patient safety implications.
Discussions centered on impurity control, regulatory compliance, and advancements in the Indian Pharmacopoeia 2026 edition.
The conclave featured participation from CDSCO, state regulators, academia, and pharmaceutical industry professionals.